TD Cowen Reiterates Buy Rating on Avidity Biosciences (RNA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 8.14 +0.14 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $22.80 | |||
| Open | $8.01 | 52 Week Low | $4.12 | |||
| Day High | $8.15 | P/E | N/A | |||
| Day Low | $7.95 | EPS | $0.00 | |||
| Volume | 13,440 | |||||
